Patent · US Active

Carbazole compounds useful as bromodomain inhibitors

US10053454B2 · kind B2 · utility

2Cited by

2References

5Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Michael A. Poss · Lawrenceville, US
David R. Tortolani · Skillman, US
Ashok Vinayak Purandare · Pennington, US
John S. Tokarski · Princeton, US
Christopher P. Mussari · Princeton, US
Muthoni G. Kamau · Lawrenceville, US
Dharmpal S. Dodd · Princeton, US
Ashvinikumar V. Gavai · Princeton Junction, US
Daniel O'Malley · New Hope, US
Tram N. Huynh · Pennington, US
Wayne Vaccaro · Yardley, US
Lalgudi S. Harikrishnan · Princeton, US

Key dates

Filing date	Feb 27, 2014
Grant date	Aug 21, 2018
Priority date	—
Expiry date	Feb 27, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to carbazole compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using the compositions in the treatment of various disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.